Global Medical Imaging Contrast Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Medical Imaging Contrast Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Medical imaging contrast refers to substances or agents used to enhance the visibility and differentiation of structures or regions within the body during various medical imaging procedures. These substances increase the contrast between different tissues or fluids, allowing healthcare professionals to obtain clearer and more detailed images, aiding in diagnosis, treatment planning, and monitoring of medical conditions.
Examples include iodine-based agents for X-rays and CT scans, gadolinium-based agents for MRI, barium sulfate for GI tract X-rays, and microbubble agents for ultrasound.
Contrast agents can be administered orally, intravenously, or through other routes, depending on the imaging modality and the specific area of the body being examined. They work by altering the way X-rays, magnetic resonance (MR) signals, or ultrasound waves interact with different tissues, resulting in better visualization of anatomical structures or pathological changes.
Global Medical Imaging Contrast market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Medical Imaging Contrast industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Medical Imaging Contrast key manufacturers include Bayer, Guerbet Group, Bracco Imaging, GE Healthcare, BeiLu Pharma, Hengrui Medicine, Lantheus and YRPG, etc. Bayer, Guerbet Group, Bracco Imaging are top 3 players and held % sales share in total in 2022.
Medical Imaging Contrast can be divided into Iodine-based Agents, Gadolinium-based Agents, Barium Sulfate and Others, etc. Iodine-based Agents is the mainstream product in the market, accounting for % sales share globally in 2022.
Medical Imaging Contrast is widely used in various fields, such as Hospitals and Clinics, etc. Hospitals provides greatest supports to the Medical Imaging Contrast industry development. In 2022, global % sales of Medical Imaging Contrast went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Medical Imaging Contrast market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Bayer
Guerbet Group
Bracco Imaging
GE Healthcare
BeiLu Pharma
Hengrui Medicine
Lantheus
YRPG
Segment by Type
Iodine-based Agents
Gadolinium-based Agents
Barium Sulfate
Others
Hospitals
Clinics
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Medical Imaging Contrast market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Medical Imaging Contrast, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Medical Imaging Contrast industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Medical Imaging Contrast in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Medical Imaging Contrast introduction, etc. Medical Imaging Contrast Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Medical Imaging Contrast market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Examples include iodine-based agents for X-rays and CT scans, gadolinium-based agents for MRI, barium sulfate for GI tract X-rays, and microbubble agents for ultrasound.
Contrast agents can be administered orally, intravenously, or through other routes, depending on the imaging modality and the specific area of the body being examined. They work by altering the way X-rays, magnetic resonance (MR) signals, or ultrasound waves interact with different tissues, resulting in better visualization of anatomical structures or pathological changes.
Global Medical Imaging Contrast market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Medical Imaging Contrast industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Medical Imaging Contrast key manufacturers include Bayer, Guerbet Group, Bracco Imaging, GE Healthcare, BeiLu Pharma, Hengrui Medicine, Lantheus and YRPG, etc. Bayer, Guerbet Group, Bracco Imaging are top 3 players and held % sales share in total in 2022.
Medical Imaging Contrast can be divided into Iodine-based Agents, Gadolinium-based Agents, Barium Sulfate and Others, etc. Iodine-based Agents is the mainstream product in the market, accounting for % sales share globally in 2022.
Medical Imaging Contrast is widely used in various fields, such as Hospitals and Clinics, etc. Hospitals provides greatest supports to the Medical Imaging Contrast industry development. In 2022, global % sales of Medical Imaging Contrast went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Medical Imaging Contrast market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bayer
Guerbet Group
Bracco Imaging
GE Healthcare
BeiLu Pharma
Hengrui Medicine
Lantheus
YRPG
Segment by Type
Iodine-based Agents
Gadolinium-based Agents
Barium Sulfate
Others
Segment by Application
Hospitals
Clinics
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Medical Imaging Contrast market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Medical Imaging Contrast, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Medical Imaging Contrast industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Medical Imaging Contrast in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Medical Imaging Contrast introduction, etc. Medical Imaging Contrast Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Medical Imaging Contrast market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.